{"id":"aerovanc","safety":{"commonSideEffects":[{"rate":"10%","effect":"Nausea"},{"rate":"5%","effect":"Vomiting"},{"rate":"8%","effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Aeruginibactin is a siderophore antibiotic that targets the Aeruginibactin receptor, inhibiting bacterial growth.","oneSentence":"Aeruginibactin antibiotic","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T05:51:04.225Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of methicillin-resistant Staphylococcus aureus (MRSA)"}]},"trialDetails":[{"nctId":"NCT03181932","phase":"PHASE3","title":"AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis","status":"COMPLETED","sponsor":"Savara Inc.","startDate":"2017-09-20","conditions":"MRSA, Cystic Fibrosis","enrollment":188},{"nctId":"NCT01746095","phase":"PHASE2","title":"Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients","status":"COMPLETED","sponsor":"Savara Inc.","startDate":"2013-03","conditions":"Cystic Fibrosis","enrollment":87},{"nctId":"NCT01537666","phase":"PHASE1","title":"Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics","status":"COMPLETED","sponsor":"Savara Inc.","startDate":"2011-11","conditions":"Healthy, Cystic Fibrosis","enrollment":25}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_1","status":"active","brandName":"AeroVanc","genericName":"AeroVanc","companyName":"Savara Inc.","companyId":"savara-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Aeruginibactin antibiotic Used for Treatment of methicillin-resistant Staphylococcus aureus (MRSA).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}